Stocks Health care HELP
NASDAQ · Health careCybin Inc. (HELP)
It posted a net loss of CA$113.1M. At March 31, 2025 it held CA$135M in cash. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on June 29, 2026.
What Cybin Inc. does
Cybin Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker HELP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -CA$113.1M | -CA$5.59 | n/a |
| 2024 | n/a | -CA$78.1M | -CA$9.41 | -CA$68.9M |
| 2023 | n/a | -CA$47.5M | -CA$0.26 | -CA$47.6M |
| 2022 | CA$0 | -CA$67.6M | -CA$0.40 | -CA$45.3M |
| 2022 | CA$864K | -CA$32.2M | -CA$0.32 | -CA$19.2M |
Latest SEC filings
What Cybin Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 23, 2026
- September 22, 2026
- September 21, 2026
- September 10, 2026
- September 9, 2026Activist stake (5% or more) SCHEDULE 13D
- September 9, 2026
- September 9, 2026Activist stake (5% or more) SCHEDULE 13D
- September 3, 2026
- September 1, 2026
- August 19, 2026
Questions about HELP
What does Cybin Inc. do?
Cybin Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker HELP.
Is Cybin Inc. profitable?
No. In fiscal 2025 it reported a net loss of CA$113.1M.
When did Cybin Inc. last report?
Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on June 29, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the foreign issuer update from September 23, 2026.
Similar companies
Follow HELP
Get an email when Cybin Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow HELP: get an email when it filesWhere the numbers come from
Financial figures are the values Cybin Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.